Advocacy intelligence hub — real-time data for patient organizations
University of Southern California — NA
Nacuity Pharmaceuticals, Inc. — PHASE3
PT. Prodia Stem Cell Indonesia — PHASE2, PHASE3
PT. Prodia Stem Cell Indonesia
University of Waterloo — NA
Zhongmou Therapeutics — PHASE1, PHASE2
Ray Therapeutics, Inc.
IRCCS San Raffaele
Suzhou UgeneX Therapeutics Co., Ltd. — EARLY_PHASE1
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts — NA
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Gislin Dagnelie, PhD
Johns Hopkins University
Michio Hirano, MD, M.D
Columbia University
📍 NEW YORK, NY
Chunhui Jiang
Eye and ENT Hospital of Fudan University
Aleksandra Rachitskaya, MD, M.D
The Cleveland Clinic
📍 CLEVELAND, OH
David Liao, MD
Retina-Vitreous Associates Medical Group, Los Angeles CA
Laryssa A Huryn, M.D., RPh
National Eye Institute (NEI)
📍 NEW YORK, NY